Advanced glycation end products induce glomerular endothelial cell hyperpermeability by upregulating matrix metalloproteinase activity

Molecular Medicine Reports

Volumn 11, Issue 6, 2015, Pages 4447-4453

  Luo, Pengli ^a   Peng, Hui ^b   Li, Canming ^b   Ye, Zengchun ^b   Tang, Hua ^b   Tang, Ying ^c   Chen, Cailian ^b   Lou, Tanqi ^b  

^a QINGHAI UNIVERSITY   (China)

^b THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Advanced glycation end products; Diabetic nephropathy; Glomerular endothelial cells; Matrix metalloproteinase; Tight junction

Indexed keywords

ANTINEOPLASTIC AGENT; CORDYCEPIN; CORDYCEPIN RUTHENIUM; PROTEIN BCL 2; PROTEIN P53; RUTHENIUM; UNCLASSIFIED DRUG; ADVANCED GLYCATION END PRODUCT; CLAUDIN 5; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE INHIBITOR; OCCLUDIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BEL 7402 CELL; CELL CULTURE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DNA BINDING; DNA HELIX; DNA SYNTHESIS; DRUG EFFECT; FLOW CYTOMETRY; HEPATOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MTT ASSAY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; CELL LINE; CELL MEMBRANE PERMEABILITY; CHEMISTRY; CYTOLOGY; DOWN REGULATION; DRUG EFFECTS; ENDOTHELIUM CELL; METABOLISM; RAT; TIGHT JUNCTION; UPREGULATION;

ANIMALS; CELL LINE; CELL MEMBRANE PERMEABILITY; CLAUDIN-5; DOWN-REGULATION; ENDOTHELIAL CELLS; GLYCOSYLATION END PRODUCTS, ADVANCED; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; OCCLUDIN; RATS; TIGHT JUNCTIONS; UP-REGULATION;

EID: 84924692264     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.3269     Document Type: Article

References (34)

1. Bhonsle HS, Korwar AM, Chougale AD, Kote SS, Dhande NL, Shelgikar KM and Kulkarni MJ: Proteomic study reveals downregulation of apolipoprotein A1 in plasma of poorly controlled diabetes: a pilot study. Mol Med Rep 7: 495-498, 2013.
2. Tooke JE: Microvasculature in diabetes. Cardiovasc Res 32: 764-771, 1996.
3. Bonnardel-Phu E, Wautier JL, Schmidt AM, Avila C and Vicaut E: Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo. Diabetes 48: 2052-2058, 1999.
4. Svensjo E, Arfors KE, Raymond RM and Grega GJ: Morphological and physiological correlation of bradykinin-induced macromolecular efflux. Am J Physiol 236: H600-H606, 1979.
5. Bi YL, Wu MF, Lu LX, Du F, Sun XT, Tang SF and Xu GT: Functions of corneal endothelial cells do not change after uptake of superparamagnetic iron oxide nanoparticles. Mol Med Rep 7: 1767-1772, 2013.
6. Leto G, Pricci F, Amadio L, Iacobini C, Cordone S and Diaz-Horta O: Increased retinal endothelial cell monolayer permeability induced by the diabetic milieu: Role of advanced non-enzymatic glycation and polyol pathway activation. Diabetes Metab Res Rev 17: 448-458, 2001.
7. Bonnardel-Phu E, Wautier JL and Vicaut E: Advanced glycation end products are involved in microvascular permeability changes observed in microcirculation of diabetic rats in vivo. J Mal Vasc 25: 122-127, 2000.
8. Soulis-Liparota T, Cooper ME, Dunlop M and Jerums G: The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the sprague-dawley rat. Diabetologia 38: 387-394, 1995.
9. Rojas A and Morales MA: Advanced glycation and endothelial functions: A link towards vascular complications in diabetes. Life Sci 76: 715-730, 2004.
10. Camici M: Renal glomerular permselectivity and vascular endothelium. Biomed Pharmacother 59: 30-47, 2005.
11. Beisswenger PJ, Makita Z, Curphey TJ, Moore LL, Jean S and Jean S: Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes. Diabetes 44: 824-829, 1995.
12. Thrailkill KM, Clay Bunn R and Fowlkes JL: Matrix metalloproteinases: Their potential role in the pathogenesis of diabetic nephropathy. Endocrine 35: 1-10, 2009.
13. Giebel SJ, Menicucci G, McGuire PG and Das A: Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier. Lab Invest 85: 597-607, 2005.
14. Death AK, Fisher EJ, McGrath KC and Yue DK: High glucose alters matrix metalloproteinase expression in two key vascular cells: Potential impact on atherosclerosis in diabetes. Atherosclerosis 168: 263-269, 2003.
15. Thrailkill KM, Bunn RC, Moreau CS, Cockrell GE, Simpson PM and Coleman HN: Matrix metalloproteinase-2 dysregulation in type 1 diabetes. Diabetes Care 30: 2321-2326, 2007.
16. Wang L, Wu J, Zhang W, Zhi Y, Wu Y, Jiang R and Yang R: Effects of aspirin on the ERK and PI3K/Akt signaling pathways in rats with acute pulmonary embolism. Mol Med Rep 8: 1465-1471, 2013.
17. Ahuja TS, Gopalani A, Davies P and Ahuja H: Matrix metalloproteinase-9 expression in renal biopsies of patients with hiv-associated nephropathy. Nephron Clin Pract 95: c100-c104, 2003.
18. Jung JY, Oh JH, Kim YK, Shin MH, Lee D and Chung JH: Acute UV irradiation increases heparin sulfate proteoglycan levels in human skin. J Korean Med Sci 27: 300-306, 2012.
19. Lauhio A, Sorsa T, Srinivas R, Stenman M, Tervahartiala T and Stenman UH: Urinary matrix metalloproteinase-8,-9,-14 and their regulators (try-1, try-2, tati) in patients with diabetic nephropathy. Ann Med 40: 312-320, 2008.
20. Peng H, Wang C, Ye ZC, Chen YR, Zhang J, Chen ZJ, Yu XQ and Lou TQ: How increased vegf induces glomerular hyperpermeability: A potential signaling pathway of rac1 activation. Acta Diabetol 47: 57-63, 2009.
21. Huang W, Eum SY, András IE, Hennig B and Toborek M: PPARalpha and PPARgamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities. FASEB J 23: 1596-1606, 2009.
22. Yang Y, Estrada EY, Thompson JF, Liu W and Rosenberg GA: Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab 27: 697-709, 2007.
23. Gu Z, Cui J, Brown S, Fridman R, Mobashery S, Strongin AY and Lipton SA: A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J Neurosci 25: 6401-6408, 2005.
24. Bojarski C, Weiske J, Schoneberg T, Schroder W, Mankertz J, Schulzke J, Florian P, Fromm M, Tauber R and Huber O: The specific fates of tight junction proteins in apoptotic epithelial cells. J Cell Sci 117: 2097-2107, 2004.
25. Sun X, Han F, Yi J, Hou N and Cao Z: The effect of telomerase activity on vascular smooth muscle cell proliferation in type 2 diabetes in vivo and in vitro. Mol Med Rep 7: 1636-1640, 2013.
26. Liu W, Hendren J, Qin XJ, Shen J and Liu KJ: Normobaric hyperoxia attenuates early blood-brain barrier disruption by inhibiting MMP-9-mediated occludin degradation in focal cerebral ischemia. J Neurochem 108: 811-820, 2009.
27. Gonzalez-Mariscal L, Tapia R and Chamorro D: Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta 1778: 729-756, 2008.
28. Anderson JM and Van Itallie CM: Physiology and function of the tight junction. Cold Spring Harb Perspect Biol 1: a002584, 2009.
29. Schneeberger EE and Lynch RD: The tight junction: A multifunctional complex. Am J Physiol Cell Physiol 286: C1213-C1228, 2004.
30. Feldman GJ, Mullin JM and Ryan MP: Occludin: Structure, function and regulation. Adv Drug Deliv Rev 57: 883-917, 2005.
31. Kiuchi-Saishin Y, Gotoh S, Furuse M, Takasuga A, Tano Y and Tsukita S: Differential expression patterns of claudins, tight junction membrane proteins, in mouse nephron segments. J Am Soc Nephrol 13: 875-886, 2002.
32. Paris L, Tonutti L, Vannini C and Bazzoni G: Structural organization of the tight junctions. Biochim Biophys Acta 1778: 646-659, 2008.
33. Harhaj NS and Antonetti DA: Regulation of tight junctions and loss of barrier function in pathophysiology. Int J Biochem Cell Biol 36: 1206-1237, 2004.
34. Xu ZC, Zhang Q and Li H: Differentiation of human hair follicle stem cells into endothelial cells induced by vascular endothelial and basic fibroblast growth factors. Mol Med Rep 9: 204-210, 2014.